SCHEMBL430960

SCHEMBL430960

CCCCOC(OCCCC)(OCCCC)C(C)O[SiH3]

nearest known ligand 0.32

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
ADRB2 P07550 1/20 0.32
ADRB1 P08588 1/20 0.32
ADRB3 P13945 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL430959 0.78
SCHEMBL11859263 0.77 ADRB2 (0.38) ADRB2ADRB1ADRB3
SCHEMBL229358 0.77
SCHEMBL27955533 0.75 DNM1 (0.31) ADRB2ADRB1ADRB3
SCHEMBL27955536 0.71 DNM1 (0.31) ADRB2ADRB1ADRB3
SCHEMBL29164930 0.68 DNM1 (0.40)
SCHEMBL354681 0.68
SCHEMBL29164945 0.68 DNM1 (0.40)
SCHEMBL10453989 0.68 DNM1 (0.31) ADRB2ADRB1ADRB3
SCHEMBL21814237 0.68 TSHR (0.33)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 47 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10702467-B2 Emulsion containing organosilicon-based portions of hollow spheres L'ORÉAL (FR) 2020-07-07 US claimed
US-20170304183-A1 EMULSION CONTAINING ORGANOSILICON-BASED PORTIONS OF HOLLOW SPHERES L'ORÉAL (FR) 2017-10-26 US claimed
US-9622946-B2 Emulsion containing organosilicon-based portions of hollow spheres L'OREAL (FR) 2017-04-18 US claimed
US-20130224267-A1 EMULSION CONTAINING ORGANOSILICON-BASED PORTIONS OF HOLLOW SPHERES L'OREAL (FR) 2013-08-29 US claimed
US-20110217346-A1 EMULSION CONTAINING ORGANOSILICON-BASED PORTIONS OF HOLLOW SPHERES L'OREAL (FR) 2011-09-08 US claimed
EP-1530961-B1 Emulsion containing hollow organosilicon particles OREAL (FR) 2009-08-05 EP claimed
US-20050118218-A1 Emulsion containing organosilicon-based portions of hollow spheres L'OREAL (FR) 2005-06-02 US claimed
US-10702467-B2 Emulsion containing organosilicon-based portions of hollow spheres L'ORÉAL (FR) 2020-07-07 US disclosed
EP-3021948-B1 OIL/OIL EMULSIONS CONTAINING PARTICLES WITH A BREAKAGE OF CURVATURE, COMPOSITIONS COMPRISING THEM AND USE OF THE PARTICLES FOR STABILIZING O/O EMULSIONS OREAL (FR) 2019-08-21 EP disclosed
US-20170304183-A1 EMULSION CONTAINING ORGANOSILICON-BASED PORTIONS OF HOLLOW SPHERES L'ORÉAL (FR) 2017-10-26 US disclosed
US-9622946-B2 Emulsion containing organosilicon-based portions of hollow spheres L'OREAL (FR) 2017-04-18 US disclosed
EP-2462197-B1 COMPOSITE PIGMENT AND METHOD FOR PREPARATION THEREOF ORÉAL L (FR) 2016-09-21 EP disclosed
WO-2016116492-A1 OIL/OIL EMULSION COMPRISING SOLID MICROPARTICLES, AT LEAST A FIRST OILY PHASE, AT LEAST A SECOND OILY PHASE AND AT LEAST A THIRD OILY PHASE THAT ARE MUTUALLY IMMISCIBLE L'OREAL (FR) 2016-07-28 WO disclosed
WO-2008022834-A1 COSMETIC COMPOSITION FOR LIGHTENING OR UNIFYING THE COMPLEXION L'OREAL (FR) 2008-02-28 WO disclosed
US-20080044365-A1 Concave or annular particles of silicone materials for increasing the sun protection factor of aqueous photoprotective compositions comprising same L'OREAL (FR) 2008-02-21 US disclosed
US-20070154500-A1 COMPOSITION CONTAINING CONCAVE PARTICLES AND A DISPERSANT, PROCESSES AND USES L'OREAL (FR) 2007-07-05 US disclosed
US-20060293431-A1 Cosmetic composition comprising silicone particles L'OREAL S.A. (FR) 2006-12-28 US disclosed
US-20050220741-A1 Cosmetic composition comprising concave particles L'OREAL S.A. (FR) 2005-10-06 US disclosed
US-20050220740-A1 Cosmetic composition comprising concave particles L'OREAL S.A. (FR) 2005-10-06 US disclosed
US-20050118218-A1 Emulsion containing organosilicon-based portions of hollow spheres L'OREAL (FR) 2005-06-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080044365-A1 Concave or annular particles of silicone materials for increasing the sun protection factor of aqueous photoprotective compositions comprising same ERCC4, BRCA1, ERCC2 ADRB2 4697/4885ADRB1 4629/4885ADRB3 4778/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.